...
首页> 外文期刊>Bioorganic and Medicinal Chemistry >Synthesis, biological evaluation and molecular modelling of diversely functionalized heterocyclic derivatives as inhibitors of acetylcholinesterase/butyrylcholinesterase and modulators of Ca2+ channels and nicotinic receptors.
【24h】

Synthesis, biological evaluation and molecular modelling of diversely functionalized heterocyclic derivatives as inhibitors of acetylcholinesterase/butyrylcholinesterase and modulators of Ca2+ channels and nicotinic receptors.

机译:合成,生物学评估和分子建模的功能多样的杂环衍生物,作为乙酰胆碱酯酶/丁酰胆碱酯酶的抑制剂以及Ca2 +通道和烟碱样受体的调节剂。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The synthesis and the biological activity of compounds 5-40 as inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), as well as modulators of voltage-dependent Ca(2+) channels and nicotinic receptors, are described. These molecules are tacrine analogues, which have been prepared from polyfunctionalized 6-amino-5-cyano-4H-pyrans, 6-amino-5-cyano-pyridines and 5-amino-2-aryl-3-cyano-1,3-oxazoles via Friedlander reaction with selected cycloalkanones. These compounds are moderate acetylcholinesterase and butyrylcholinesterase inhibitors, the BuChE/AChE selectivity of the most active molecules ranges from 10.0 (compound 29) to 76.9 (compound 16). Interestingly, the 'oxazolo-tacrine' derivatives are devoid of any activity. All compounds showed an important inhibitory effect on the nicotinic acetylcholine receptor. Most of them also blocked L-type Ca(2+) channels, and three of them, 64, 19 and 67, the non-L type of Ca(2+) channels. Molecular modelling studies suggest that these compounds might bind at the peripheral binding site of AChE, which opens the possibility to design inhibitors able to bind at both, the catalytic and peripheral binding sites of the enzyme.
机译:描述了化合物5-40作为乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BuChE)的抑制剂以及电压依赖性Ca(2+)通道和烟碱样受体的调节剂的合成和生物学活性。这些分子是他克林类似物,其由多官能化的6-氨基-5-氰基-4H-吡喃,6-氨基-5-氰基吡啶和5-氨基-2-芳基-3-氰基-1,3-制备。恶唑通过弗里德兰德反应与选定的环烷酮反应。这些化合物是中度乙酰胆碱酯酶和丁酰胆碱酯酶抑制剂,活性最高的分子的BuChE / AChE选择性范围为10.0(化合物29)至76.9(化合物16)。有趣的是,“恶唑酮-他克林”衍生物没有任何活性。所有化合物均显示出对烟碱乙酰胆碱受体的重要抑制作用。他们中的大多数人还封锁了L型Ca(2+)通道,其中三个,即64、19和67,这是非L型Ca(2+)通道。分子模型研究表明,这些化合物可能在AChE的外围结合位点结合,这为设计能够在酶的催化结合位点和外围结合位点结合的抑制剂打开了可能性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号